Better Access. Better Lives.
Who we are
We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do.
Our approach
We believe that a vertically integrated approach, from cell line development through fill and finish manufacturing, gives us the control, scale and speed needed to achieve our mission. We maintain our singular focus on what we do best while relying on the deep expertise of our partners for commercialization.
Our Pipeline
We are committed to developing and manufacturing high-quality, cost-competitive biosimilars. We continually evaluate additional pipeline opportunities to bring a strategic and robust selection of biologic medicines to patients around the world.
Latest news
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
Join our team
Here at Alvotech, we want our employees to feel inspired in their careers and challenged by interesting and meaningful work. That’s why we are proud of our purpose-driven culture. We are always interested in speaking to passionate, experienced individuals. Are you ready to join our growing team?